Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Digital cognitive behavioral therapy for insomnia" is not a molecule, receptor, enzyme, or canonical therapeutic target, but rather a structured, evidence-based, psychotherapeutic intervention delivered via digital platforms to treat insomnia. It involves cognitive and behavioral strategies to change thoughts and behaviors that perpetuate insomnia. Digital versions use mobile apps or web platforms to deliver content, monitor progress, and provide automated or guided support, and have demonstrated efficacy for improving sleep and reducing symptoms of depression and anxiety in individuals with insomnia[1][2][4][5][3]. However, it is not a molecular or biological target, and is instead a form of psychotherapy utilized as a non-pharmacological treatment for insomnia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Digital cognitive behavioral therapy for insomnia (dCBT-I).